TianYu Bio-Technology Co (603717.SS) Stock Price
TianYu Bio-Technology Co Price
Revenue has compounded at 3.6% per year over the past 13 years to 725.59 M CNY. Earnings per share have grown at 8.3% per year over the last 7 years. TianYu Bio-Technology Co's net margin stands at -14.7%, up from -33.7% several years earlier. TianYu Bio-Technology Co currently offers a dividend yield of about 2.36%. The payout ratio is around 38% of earnings.
TianYu Bio-Technology Co stock price
TianYu Bio-Technology Co business model & stock analysis
Frequently asked questions about TianYu Bio-Technology Co
5 analysts currently rate the TianYu Bio-Technology Co stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the TianYu Bio-Technology Co share trades at 0.81 EUR (6.06 CNY).
The revenue cannot currently be calculated for TianYu Bio-Technology Co.
The profit cannot currently be calculated for TianYu Bio-Technology Co.
The P/E ratio cannot be calculated for TianYu Bio-Technology Co at the moment.
The P/S cannot be calculated for TianYu Bio-Technology Co currently.
The Eulerpool Quality Score for TianYu Bio-Technology Co is 1/10.
The ISIN of TianYu Bio-Technology Co is CNE1000030W1. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of TianYu Bio-Technology Co is 603717.SS. The ticker symbol is used to trade TianYu Bio-Technology Co shares on the stock exchange.
TianYu Bio-Technology Co stock
TianYu Bio-Technology Co Peer Group
TianYu Bio-Technology Co FIGI
All fundamentals and in-depth analysis of TianYu Bio-Technology Co
Our stock analysis for TianYu Bio-Technology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TianYu Bio-Technology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.